atypical antipsychotics (Lilly)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameatypical antipsychotics (Lilly)
Drug Alias NameFMPD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonistsHistamine H1 receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists +[4] 
TargetsHistamine H1 receptorDopamine D2 receptorSerotonin 2a (5-HT2a) receptor +[4] 
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A